Press Release

October 05, 2022 | Press Release
Immunitas Therapeutics to Present Preclinical Data on IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Read More
September 21, 2022 | Press Release
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
Read More
August 23, 2022 | Press Release
Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund
Read More
July 13, 2022 | Press Release
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
Read More
May 27, 2022 | Press Release
Multi-omics Startup Pleno Inc. Announces $15 Million in Pre-Series A Funding
Read More
May 18, 2022 | Press Release
ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO
Read More
May 10, 2022 | Press Release
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners
Read More
April 12, 2022 | Press Release
Aspen Neuroscience Launches First Patient Screening Study for Planned Clinical Trial of Personalized Cell Replacement in Parkinson’s Disease
Read More
March 01, 2022 | Press Release
ProJenX Announces First Person Dosed in Phase 1 Study of Prosetin
Read More
February 16, 2022 | Press Release
ProJenX launches to advance novel, targeted therapies for ALS and other brain diseases
Read More